---
schema_version: "secwatch.filing_event.v1"
accession: "0001682852-26-000057"
form_type: "8-K"
ticker: "MRNA"
cik: "0001682852"
company_name: "Moderna, Inc."
filed_at: "2026-05-01T23:59:59+00:00"
generated_at: "2026-05-15T00:20:14.652640+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Moderna Q1 2026 revenue $389M, GAAP net loss $(1.3)B including $0.9B litigation charge

## Summary
- Revenue $389M (+$281M YoY); ~80% from international; GAAP EPS $(3.40) vs $(2.52) YoY.
- Net loss $(1.3)B includes $0.9B non-recurring litigation settlement charge; cash $7.5B.
- Reaffirms up to 10% revenue growth in 2026; cost of sales guidance ~$1.8B including charge.
- EU approved mNEXSPIKE and mCOMBRIAX (flu+COVID combo); Phase 3 initiated for intismeran in NSCLC.
- R&D expenses down 24% YoY to $649M; SG&A down 18% to $173M.

## SEC filing metadata
- accession: 0001682852-26-000057
- form_type: 8-K
- ticker: MRNA
- cik: 0001682852
- company_name: Moderna, Inc.
- filed_at: 2026-05-01T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1682852/000168285226000057/0001682852-26-000057-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1682852/000168285226000057/mrna-20260501.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001682852-26-000057
- JSON: https://secwatch.observer/filing/0001682852-26-000057.json
- Plain text: https://secwatch.observer/filing/0001682852-26-000057.txt

## Key facts
- Earnings Releases
  Moderna, Inc. reported first quarter ended March 31, 2026 results: revenue $389 million, net income $(1.3) billion, EPS $(3.40).
  - Period: first quarter ended March 31, 2026
  - Revenue: $389 million
  - Net income: $(1.3) billion
  - EPS: $(3.40)
  - Result: reported results
  source text: Total revenue for the first quarter of 2026 was $389 million, an increase of $281 million compared to the same period in 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1682852/000168285226000057/0001682852-26-000057-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.